key: cord-1033730-c6wq9i5h
authors: Omame, Andrew; Nwajeri, Ugochukwu K.; Abbas, M.; Onyenegecha, Chibueze P.
title: A fractional order control model for Diabetes and COVID-19 co-dynamics with Mittag-Leffler function
date: 2022-01-07
journal: Alexandria Engineering Journal
DOI: 10.1016/j.aej.2022.01.012
sha: df17bc88e5697523ee254ea0f492993d7d09989a
doc_id: 1033730
cord_uid: c6wq9i5h

The aim of this paper is to present and analyze the fractional optimal control model for COVID-19 and diabetes co-dynamics, using the Atangana-Baleanu derivative. The positivity and boundedness of the solutions was shown by the method of Laplace transform. The existence and uniqueness of the solutions of the proposed model were established using Banach fixed point Theorem and Leray-Schauder alternative Theorem. The fractional model was also shown to be Hyers-Ulam stable. The model was fitted to the cumulative confirmed daily COVID-19 cases for Indonesia. The simulations of the total number of hospitalized individuals co-infected with COVID-19 and diabetes, at different face-mask compliance levels, when vaccination strategy is maintained reveals that the total number of hospitalized co-infection cases decreases with increase in face-mask compliance levels, while maintaining COVID-19 vaccination. The simulation results show that to curtail COVID-19 and diabetes co-infections, policies and measures to enforce mass COVID-19 vaccination and strict face-mask usage in the public must be put in place. To further cut down the spread of COVID-19 and diabetes co-infection, time dependent controls are added into the fractional model, and the obtained optimal control problem investigated via the Pontryagin’s Maximum Principle.

This section presents some definitions and theorems applied in the paper.

Suppose a function f ∈ C 1 (0, T ) such that T > 0 and 0 < ≤ 1, then Atangana-Beleanu (AB) 

where G( ) = 1 − + Γ( ) is a normalization function with G(0) = G(1) = 0 and E β is a Mittag-Leffler function.

abc a I t f (t) = 1 − G( ) f (t) + G( )Γ( ) t a (t − ϕ) −1 f (ϕ)dϕ.

where L is the Laplace transform operator.

The Atangana-Beleanu derivative possesses a non-singular kernel. The choice of non-singular kernel guarantees a better analysis of physical problems unlike other fractional derivatives and other tools in classical calculus.

Let ψ 1 : [0, T ] → R and ψ 2 a positive function [0, T ] . Suppose that α > 0 and 0 < < 1 are the constants such that the following holds:

Then there exists a constant Υ c = Υ c ( ) such that

2 Formulation of the model At any given time, t, the epidemiological states are: unvaccinated susceptible individuals (Ψ h (t)), vaccinated individuals against COVID-19, Ψ vh , diabetic susceptible individuals (Ψ d (t)), COVID-19 infected (non-diabetic) (Υ c (t)), isolated individuals with COVID-19 (non-diabetic) (Φ c (t)), COVID-19 recovered individuals (non-diabetic) (Γ c (t)), individuals with dual infections (Υ cd (t)), individuals with dual infections (hospitalized) (Φ cd (t)), COVID-19 recovered individuals (diabetic) (Γ cd (t)). Individuals are recruited into the population at the rate, Θ h . Unvaccinated susceptibles, Ψ h (t) acquire COVID-19 at the rate πc(1−ηϑ)(Υc+Υcd) Nh , where, π c denotes the COVID-19 contact rate. η is the face-mask compliance rate and ϑ denotes the efficacy of the face-mask. Individuals in this epidemiological state acquire diabetes at the rate d1 . Furthermore, they die natural death, which is assumed same for individuals in all compartments of the model, at the rate μ h . Vaccinated susceptibles, Ψ vh (t) acquire COVID-19 at a reduced rate (1 − χ) , where λ c is accounting for increased susceptibility rate for diabetics [9, 10] . Also, we have assumed that the transmissibility rate for singly infected and co-infected persons is the same, as there is no evidence yet to justify otherwise. The other transitions in the model are given in the model equations 1, with all the model parameters well defined in Table 1 .

The total population at time, t is given by

The model is given thus,

with corresponding initial conditions

Here we consider the non-negativity of all the solutions in our system. Application of Laplace transform of the Atangana-Beleanu derivative in Caputo sense plays a crucial in this case. Following similar arguments to those in [26] , we suppose that the point t * satisfies Then let Ψ h (t) = 0 and Ψ h (t) < 0 for all 0 ≤ t ≤ t * , then there exists the quantity P such that

We now seek for additional force function −g(t) such that

can be ascertained. Thus application of Laplace transform gives

Application of inverse Laplace transform expressed as Mittag-Leffler function and neglecting the non-positive quantity gives the following relation

. Thus the non-negativity of the solution Ψ h (t) is now defined by

It is worth mentioning that the choice of order ϕ for the fractional derivatives and the parameter P play an important role in proving the non-negativity of the solutions of the fractional model. The use of non-singular kernel in Atangana-Beleanu fractional derivative gives a better space for this case which cannot be accommodated in the classical calculus or fractional derivatives with singular kernel.

Similar approach yields the non-negativity of the solutions Ψ vh , Ψ d (t), Υ c (t), Φ c (t), Γ c (t), Υ cd (t), Φ cd (t) and Γ cd (t) respectively as

We investigate the region where the solutions of the system are biologically and mathematically well-posed. The compartments are human population and thus the parameters used in the system are assumed positive. Therefore we consider the total of human population at the time, t;

Applying Atangana-Beleanu fractional derivative on both sides and plugging in respective functions gives

Application of Laplace transform and its inverse expressed as a Mittag-Leffler function, we deduce that

Thus, the biologically feasible domain is

For any mathematical system, it is always desirable to know that if a solution to the problem exists and if so, is it the only solution? This subsection deals with answering the above posed question with reference to the fractional order model under consideration. Consider

, Γ cd (0)) represents the corresponding initial condition. We denote the vector F as,

is the Banach space of all continuous functions defined in [0, T ] → R equipped with a Chebychev norm. Moreover, let F (., x) : R → R be bounded on R and fulfill a Lipschitz condition with respect to the second argument; thatis,,

with some constant L F > 0 independent of t, φ 1 and φ 2 . 

where the right hand side of the inequality is the Binomial expansion of (1− )

Proof. Following the similar approach as given in [45] and by applying the integral operator of Atangana-Beleanu fractional integral in Caputo sense of order ϕ on both sides of (4), we obtain the following non-linear Volterra integral equation

Obviously every solution of (7) is also a solution of the initial value problem (4)-(5) and vice-versa. Let the operator Ω :

By substituting (7) into (8), we consider the following equation

To prove the uniqueness of the solution, we show that the operator Ω has a fixed unique point. Note that the Chebyshev norm . [0,T ] ) is the supremum norm over the interval [0, T ] which is defined by

In this case, C 1 [0, T ], R 9 equipped with Chebyshev norm . [0,T ] ) is a Banach space. Using (9), the Lipschitz condition and triangle inequality we get

that is,

If the condition stated in (6) holds true, then by Banach's contraction principle, Ω has a unique fixed point which is a solution of the initial value problem (4)-(5) and hence a solution to the system (1)-(2). Next we present the existence of the solution of (4)-(5) which is based on the non-linear Leray-Schauder type theorem [54] .

Then (1)-(2) possess at least a unique solution on the interval 0 ≤ t ≤ T.

Proof. We first show that Ω : C 1 (..) → C 1 (..) is totally continuous. For this, we consider a sequence {φ m+1 } such that φ m+1 → φ 0 ∈ C 1 (..). Thus

Thus, F is totally continuous which leads to the following

We now show that the operator Ω is a one-to-one correspondence on bounded sets in C 1 (..) That is, we show that for > 0 there exists L F > 0 such that for every φ ∈ B , we have

We also show that the operator Ω maps bounded set into equi-continuous sets of

which proves that Ωφ is equi-continuous as t 1 → t 2 , the right hand side of the inequality goes to zero. Thus by Arzela-Ascoli theorem, we conclude that Ω :

Using (B2) we get

Thus

Using Lemma (1.1), there exists Υ c = Υ c ( ) such that

It follows that

Thus Ω :

Thus, an operator Ω has a fixed point φ ∈ E by non-linear Leray-Schauder alternative Theorem [54] .

The model possesses a disease free equilibrium Ω 0 which we obtained by setting the right hand side of the system (1) to zero which yields

The linear stability of the disease free equilibrium, Ω 0 can be established using the next generation operator method [49] on the system (1).

The next generation matrices are, respectively, given by

Using the approach shown in [49] , the basic reproduction number of the model (1) is given by (where ρ is the spectral radius)

The result below follows from Theorem 2 in [49] .

Proof.

The local stability of the model (1) is analyzed by the Jacobian matrix of the system (1) evaluated at the disease-free equilibrium, Z 0 , given by:

The characteristic equation of the above matrix is given by

The eigenvalues are

and the solutions of

Following the Routh-Hurwitz criterion, the equation above will have roots with negative real parts if and only if R 0Ψ < 1. Thence, the DFE, Z 0 is locally asymptotically stable if R 0Ψ < 1.

We employ the approach in [50] to investigate the global asymptotic stability (GAS) of the DFE of the model. The system (1) is re-written as:

where

represents the infected compartments. U 0 = (T * , 0) denotes the DFE of the system. For local asymptotic stability, the following conditions must be met: (Δ 1 ): For abc 0 D t T = P (T , 0), T * is globally asymptotically stable (GAS), 0) , Ω is the invariant region. If (1) fulfills the above conditions, then the following result holds:

The fixed point U 0 = (T * , 0) is a globally asymptotic stable (GAS) equilibrium of (1) if R 0Ψ < 1 (LAS) and that conditions (Δ 1 ) and (Δ 2 ) are met.

where T represents the number of non-infectious compartments and Y represents the number of infectious compartments

It is seen that,Ψ(T , Y) ≥ 0. Thus, the DFE is GAS.

In this subsection, we employ similar approach in [46] where Hyers-Ulams stability approach will be used in the fractional system (1)-(2) given by the initial value problem (4)-(5). Proof. Recall that Theorem (2.1) guarantees that there exists a unique solution to the fractional model. Letφ(t) be another unique solution to the fractional model. Note that every solution of (7) is also a solution of the IV P and vice-versa. Also,

where L F > 0 is the Lipschitz constant. Let L F = p and q = (1− )

Adopting the inequality (15) into the fractional system (1)-(2) yields the following

Hence the solution of the fractional model (1)-(2) of order is Hyers-Ulam stable.

The numerical scheme given in [51] shall now be applied to approximate the Atangana-Baleanu fractional Integral. The numerical method used combines the two-step Lagrange polynomial and the fundamental theorem of fractional calculus. This method has proven be highly accurate and efficient, user-friendly and converges quickly to the exact solution even with a large step of discretization [51] . Applying Atangana-Beleanu fractional integral on both sides of the initial value problem (4)- (5) gives

At t = t ε+1 = (ε + 1)h , where h = t ε+1 − t ε is the time space, the above equation discretizes to

When we adopt Lagrange two-points interpolation into (16), we have

If we apply (17), then (1)-(2) becomes;

Since the total population of Indonesia is 273,523,621 [56] , we set Ψ h (0) = 260, 000, 000. Also, we set Ψ vh (0) = 345, 605, following from the estimate in [56] . The total number of recovered individuals is set as Γ c (0) = 993, 117 [56] . The paper [58] gave some diabetes report. Hence, the diabetic susceptible population is set at Ψ d (0) = 16, 000, 000. For the other initial conditions, we assumed: Φ cd (0) = 1, 090, 000 and Γ cd = 0. The fmincon optimization toolbox [59] is used for the model fitting. The model (1) is fitted to the cumulative confirmed daily COVID-19 cases for Indonesia from February 11, 2021 to August 26, 2021. As shown in Figure 1 , the fractional order model (1) 

We now give a brief run down of previous results on COVID-19 and diabetes/co-morbidity co-infection: Kouidere et al [40] , in their work on integer model for COVID-19 and diabetes, showed that during epidemic outbreak such as COVID-19, diabetics must be followed up to avoid complications. Ssebuliba et al. [41] in a paper on COVID-19 dynamics in a partially co-morbid population, reported that infections at the community level increase very rapidly when detection rates for both individuals with or without co-morbidities are decreased. Also, Khan et al. [42] in a work on integer order model for diabetics exposed to COVID-19 infection, showed that in order to eliminate chaos and period-doubling bifurcations, quarantine was a necessity in the COVID-19 environment. Furthermore, the authors in [43] in paper on COVID-19 and co-morbidity with COVID-19 re-infection, showed that re-infection could induce backward bifurcation in the model. Moreover, Ozkose and Yavuz [44] , in a recent work on COVID-19 and diabetes with hereditary traits, using real data from Turkey, showed that the Caputo fractional derivative greatly influenced the dynamics of the two diseases in the population. As treatment and non-pharmaceutical interventions alone can not curtail COVID-19 spread, amid rising variants of concern, our current work considers a more comprehensive fractional optimal control model for the co-dynamics of COVID-19 and diabetes (via the best and most preferred Atangana-Baleanu derivative) incorporating vaccination in order assess to what extent the current available COVID-19 vaccines could decrease the spread of COVID-19 and its co-infection with diabetes. This was not considered by previous studies in this area.

Simulation of the the total number of individuals co-infected with COVID-19 and diabetes, at different facemask compliance levels, when vaccination strategy is maintained, is depicted by Figure 2 . Here, the fractional order value, = 0.80. Also, the COVID-19 contact rate π c = 1.0991 while the vaccine efficacy is set at χ = 0.95 and vaccination rate, v = 0.4. The face-mask is assumed to be 95% effective in preventing new infections. The facemask compliance level η is varied from 0.15 to 0.60. It is observed that the combined strategy leads to significant decrease in the co-infection new cases over time. The simulations of the total number of hospitalized individuals co-infected with COVID-19 and diabetes, at different face-mask compliance levels, when vaccination strategy is maintained, is depicted by Figure 3 . Here, the fractional order value, = 0.80 and the COVID-19 contact rate π c = 1.0991. The vaccine efficacy is assumed χ = 0.95 and vaccination rate set at v = 0.4. The face-mask is assumed to be 95% effective in preventing new infections. The face-mask compliance level η is varied from 0.15 to 0.60. It is observed that the total number of hospitalized co-infection cases decreases with increase in face-mask compliance levels. The simulation results show that to curtail COVID-19 and diabetes co-infections, policies and measures to enforce mass COVID-19 vaccination and strict face-mask usage in the public must be enforced. Table 1 .

Simulation of the total number of individuals infected with COVID-19, when COVID-19 vaccination is not administered and when it is implemented, is depicted by Figure 4 . Here, the fractional order value, = 0.80, the COVID-19 contact rate is set at π c = 1.0991, so that the basic reproduction number is R 0Ψ = 2.4390 > 1. When only face-mask usage is strictly enforced, but with no COVID-19 vaccination, the infection cases increase steadily. However, it is observed that incorporating vaccination strategy with vaccine efficacy at χ = 0.95 and vaccination rate at v = 0.4 per day, will avert about 1,648,000 new COVID-19 cases after 200 days. Also, Simulation of the total number of individuals infected with COVID-19, when COVID-19 vaccination is not administered and when it is implemented, is depicted by Figure 5 . Here, also, the fractional order value, = 0.80, the COVID-19 contact rate is set at π c = 1.0991, so that the basic reproduction number is R 0Ψ = 2.4390 > 1. The plot reveals that incorporating vaccination strategy with vaccine efficacy at χ = 0.95 and vaccination rate at v = 0.4 per day, will avert about 6,991,000 new active COVID-19 cases at the end of 200 days.

Simulations of the total number of individuals infected with COVID-19, at different face-mask compliance levels, Table  1 . Table 1 . Table 1 .

when vaccination strategy is maintained, is depicted by Figure 6 . Here, the fractional order value, = 0.80. Also, the COVID-19 contact rate π c = 1.0991 while the vaccine efficacy is set at χ = 0.95 and vaccination rate, v = 0.4. The face-mask is assumed to be 95% effective in preventing new infection. The face-mask compliance level η is varied from 0.15 to 0.60. It is observed that the infection peaks decrease with increase in compliance levels. Also, simulations of the total number of isolated and hospitalized individuals infected with COVID-19, at different facemask compliance levels, when vaccination strategy is maintained, is depicted by Figure 7 . Here, the fractional order value, = 0.80. Also, the COVID-19 contact rate π c = 1.0991 while the vaccine efficacy is set at χ = 0.95 and vaccination rate, v = 0.4. The face-mask is assumed to be 95% effective in preventing new infections. The face-mask compliance level η is varied from 0.15 to 0.60. It is seen from the figure that the higher the compliance level in face-mask usage, the lower the number of hospitalized patients with COVID-19. Table 1 . Table 1 .

In this section, we incorporate time dependent controls into the fractional order model. We define the controls as follows:

• The control u 1 (t) represents COVID-19 preventive efforts

• The control u 2 (t) is the treatment efforts for those infected with COVID-19

The controls u 1 and u 2 satisfies 0 ≤ u 1 , u 2 ≤ 0.9. Thus,

We then obtain

High stability is obtained by

The scheme is thus used in Eq. 34

Simulation of the Fractional optimal control model for individuals co-infected with COVID-19 and diabetes, when only COVID-19 preventive strategy (u 1 ) is implemented, is depicted in Figure 8 . Here, the fractional order value, = 0.90. while the COVID-19 contact rate, π c = 0.5776. It is observed from this figure that a total of 67,906,600 co-infected cases were averted after 200 days. Also, this strategy averts about 434,700 hospitalized co-infected cases, after about 100 days, as shown in Figure 9 . The control profile for this strategy is shown in Figure 10 . This shows that COVID-19 preventive strategy involving vaccination and face-mask usage will not only reduce new COVID-19 cases, but will equally cut down COVID-19 and diabetes co-infection cases. Public health agencies and policy makers must therefore drive the campaign for mass vaccination of susceptible individuals and usage of face-masks and sanitizers in public places. This effort will have very high positive impact on diabetics, so as to reduce complications with severe COVID-19 illness.

Simulations of the Fractional optimal control model for individuals co-infected with COVID-19 and diabetes, when only COVID-19 treatment strategy (u 2 ) is implemented, is depicted in Figure 11 . Here, the fractional order value, = 0.90. while the COVID-19 contact rate, π c = 0.5776. It is observed from this figure that a total of 67,500,000 co-infected cases were averted after 200 days. Also, this strategy averts about 177,900 hospitalized coinfected cases, after about 100 days, as shown in Figure 12 . The control profile for this strategy is presented in Figure 13 . This shows that effective treatment for COVID-19 treatment will not just reduce new covid-19 cases but will also help bring down the total hospitalized co-infected cases in the population. Table 1 . Table 1 . Figure 10 : Control profile when only COVID-19 preventive strategy (u 1 ) is implemented. Here, the fractional order value, = 0.90. Also, π c = 0.5776. All other parameters are as in Table 1 . Table 1 . Table 1 . Figure 13 : Control profile when only COVID-19 treatment control (u 2 ) is implemented. Here, the fractional order value, = 0.90. Also, π c = 0.5776. All other parameters are as in Table 1 .

In this article, we have analyzed a fractional order model for COVID-19 and diabetes codynamics, using the Atangana-Baleanu derivative. The positivity and boundedness of the solutions were established by the method of Laplace transform. The existence and uniqueness of the model solution were established with the aid of Banach fixed point theorem and Leray-Schauder alternative Theorem. The disease free equilibrium of the model was shown to be locally and globally asymptotically stable when the associated reproduction number is below one. Furthermore, the fractional model was shown to be Hyers-Ulam stable. Using the fmincon function in the Optimization Toolbox of MATLAB, the model was fitted to the cumulative confirmed daily COVID-19 cases for Indonesia from February 11, 2021 to August 26, 2021. Some parameters related to COVID-19 and its co-infection with diabetes were estimated from the data fitting. The simulations of the total number of isolated and hospitalized individuals co-infected with COVID-19 and diabetes, at different face-mask compliance levels, when vaccination strategy is maintained reveals that the total number of isolated and hospitalized co-infection cases decreases with increase in face-mask compliance levels, while maintaining COVID-19 vaccination. The simulation results show that to curtail COVID-19 and diabetes co-infections, policies and measures to enforce mass COVID-19 vaccination and strict face-mask usage in the public must be put in place. To further mitigate the spread of COVID-19 and diabetes co-infection, time dependent controls are added into the fractional model, and the obtained optimal control problem investigated via the Pontryagin's Maximum Principle. As different COVID-19 variants continues to spread across the world, efforts must be enhanced to avert co-infection with other co-morbidity, especially among high risk population such as those with diabetes. This model has shown that fractional derivative is the most ideal in dealing with complex epidemic models such as COVID-19 and diabetes co-infection.

Our model focused basically on COVID-19 and diabetes co-infection. The emergence of highly transmissible and deadlier variants of COVID-19 calls for more research in this area, as co-infection between COVID-19 and different variants of COVID-19 will be an interesting area for further research. Further studies can consider more than one fractional derivative for the solution of the model. We may also consider using semi-analytic methods such as the Laplace Adomian decomposition method or Homotopy analysis method for the solution of the model, taking different sub-populations.

The authors declare that they have no conflict of interests. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas

Diabetes and infection: assessing the association with glycaemic control in population-based studies

New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records

Diabetes mellitus and cause-specific mortality: a population-based study

WHO Declares COVID-19 a Pandemic

Evaluating comorbidity in total hip and knee arthroplasty: available instruments

Centres for Disease Control and Prevention (CDC), Coronavirus Disease 2019 (COVID-19)

Attitudinal, regional and sex related vulnerabilities to COVID-19: Considerations for early flattening of curve in Nigeria

Prevalence of diabetes in the 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus: a systematic review and meta-analysis

Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Prevalence of comorbidity and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

A fractional order Covid-19 epidemic model with Mittag-Leffler kernel

A study on transmission dynamics of HIV/AIDS model through fractional operators Results in Physics

On the co-infection of dengue fever and Zika virus

A mathematical model for the coinfection of Buruli ulcer and Cholera

COVID-19 and dengue co-infection in Brazil: optimal control and cost-effectiveness analysis

A Co-infection model for HPV and Syphilis with Optimal Control and Cost-Effectiveness Analysis

Fractional optimal control dynamics of coronavirus model with MittagLeffler law

Fractional optimal control of COVID-19 pandemic model with generalized Mittag-Leffler function

Optimal control for a time delay multi-strain tuberculosis fractional model: a numerical approach

Optimal control for a nonlinear mathematical model of tumor under immune suppression: a numerical approach

Optimal control for a fractional tuberculosis infection model including the impact of diabetes and resistant strains

New fractional derivatives with nonlocal and non-singular kernel: theory and applications to heat transfer model

A note on fractional order derivatives and table of fractional derivatives of some special functions

SIR epidemic model with Mittag-Leffler fractional derivative

Analytical solutions and numerical schemes of certain generalized fractional diffusion models

Analysis and Dynamics of Fractional Order Covid-19 Model with Memory Effect

A fractional-order multi-vaccination model for COVID-19 with nonsingular kernel

Analysis of fractional blood alcohol model with composite fractional derivative

Fractional order model of coronavirus disease 2019 (COVID-19) with governmental action and individual reaction

SARS-CoV-2 infection with lytic and non-lytic immune responses: A fractional order optimal control theoretical study

Fractional Model of Ebola Virus In Population of Bats In Frame of Atangana-Baleanu Fractional Derivative

I Khan A Fractional Epidemic Model with Mittag-Leffler Kernel for COVID-19

Non-singular fractional approach for natural convection nanofluid with Damped thermal analysis and radiation, Case Studies in Thermal Engineering

Mathematical analysis and numerical investigation of advection-reaction-diffusion computer virus model

Analysis of a fractional order model for HPV and CT coinfection

Dynamic model of COVID-19 and citizens reaction using fractional derivative

A fractional order dengue fever model in the context of protected travelers

Optimal Control of Mathematical modeling of the spread of the COVID-19 pandemic with highlighting the negative impact of quarantine on diabetics people with Cost-effectiveness

Mathematical modelling of COVID-19 transmission dynamics in a partially comorbid community

Bifurcation analysis of a discrete-time compartmental model for hypertensive or diabetic patients exposed to COVID-19

Analysis of COVID-19 and comorbidity co-infection Model

Investigation of interactions between COVID-19 and diabetes with hereditary traits using real data: A case study in Turkey

A fractional-order model for COVID-19 and Tuberculosis Co-infection using Atangana-Baleanu derivative

Fractional optimal control of COVID-19 pandemic model with generalized Mittag-Leffler function

Existence results for fractional order functional differential equations with infinite delay

A fractional order Covid-19 epidemic model with Mittag-Leer kernel

Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission

Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction

New numerical approximation of fractional derivative with non-local and non-singular kernel: Application to chaotic models

The Mathematical Theory of Optimal Processes

Optimal Control Applied to Biological Models

Fixed Point Theory

A Predictor-Corrector Approach for the Numerical Solution of Fractional Differential Equations

FDA Briefing Document Pfizer-BioNTech COVID-19 Vaccine

Genetic algorithms for modelling and optimisation

with corresponding initial conditionsWe seek to minimize the number of COVID-19-infected and the co-infection cases as well as the cost of implementing the controls u 1 (t) and u 2 (t), subject to the state system (19) . The following quadratic objective functional is defined. This quadratic form was also used in [43] .T is the final time. An optimal control, u * 1 , u * 2 , is to be found, such thatThe Pontryagin's Maximum principle [52] transforms (19) , (20) and (21) into a problem of minimizing a Hamiltonian, J , with respect to the control functions, u 1 andu 2 :Theorem 6.1 For an optimal control set u 1 , u 2 that minimizes J over U , there are adjoint variables, λ 1 , λ 2 , ..., λ 9 satisfyingFurthermore,Proof of Theorem 6.1 Let U * = (u * 1 , u * 2 ) be an optimal control pair and Ψbe the corresponding state solutions. Following from [52] , there exist adjoint variables satisfying:Differentiating the Hamiltonian, J with respect to the controls(u 1 , u 2 ) at t, we haveTherefore, following from [53] , the following is obtained

Consider a general initial value problem [19] abcApplying the fundamental theorem of fractional calculus to eq. 30 above, we have thatWith the help of the normalization function, G( ) = 1 − + γ( ) at t n+1 , after discretization, we have Approximating r(η, H(η)) by the two-step Lagrange interpolation [55] , we obtain